The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.

Pfizer has a huge 6% yield and a payout ratio well over 100%, yet the company is still maintaining the dividend.

Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the balance sheet leaves ...

The pharmaceutical stock is struggling, but its dividend can be highly valuable to income investors.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer's 5.91% yield draws most of the headlines, but a quietly rerated stock and a pipeline loaded with 2026 catalysts are ...

PFE's non-COVID growth, oncology pipeline and cost cuts offer a path forward as COVID sales fall and patent losses loom.

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies announced Thursday.

COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...

Pfizer agreed to a $44 million Chantix settlement. Here's who may qualify, how to file a claim and the deadline to submit.

The beaten-down pharmaceutical stock was revived after it posted an estimates-beating quarter.